International Isotopes

OverviewSuggest Edit

International Isotopes, Inc. manufactures a range of nuclear medicine calibration and reference standards, cobalt teletherapy sources, and radioisotopes and radiochemicals for medical research, pharmacy compounding, and clinical applications. It operates through six segments: Nuclear Medicine Standards, Cobalt Products, Radiochemical Products, Fluorine Products, Radiological Services, and Transportation.
TypePublic
Founded1995
HQIdaho Falls, US
Websiteintisoid.com

Latest Updates

Employees (est.) (Dec 2018)30(+8%)

International Isotopes Office Locations

International Isotopes has an office in Idaho Falls
Idaho Falls, US (HQ)
4137 Commerce Cir
Show all (1)

International Isotopes Financials and Metrics

International Isotopes Revenue

USD

Net income (Q1, 2019)

56.5k

EBIT (Q1, 2019)

142.6k

Market capitalization (8-Oct-2018)

41.0m

Cash (31-Mar-2019)

398.6k
International Isotopes's current market capitalization is $41 m.
Annual
USDFY, 2013FY, 2015FY, 2016FY, 2017FY, 2018

Cash

456.4k398.0k314.5k409.3k828.0k

Accounts Receivable

1.0m1.1m774.3k635.0k820.4k

Inventories

1.5m1.1m1.5m2.0m2.8m

Current Assets

3.6m3.1m3.3m3.7m4.7m
USDY, 2019

Financial Leverage

29.3 x
Show all financial metrics

International Isotopes Online and Social Media Presence

Embed Graph

International Isotopes News and Updates

International Isotopes Inc. Announces Financial Results for the First Quarter 2019

IDAHO FALLS, Idaho, May 16, 2019 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) (the "Company") announces its financial results for the three months ended March 31, 2019. Total revenue for the Company for the three months ended March 31, 2019 was $2,527,852 as compared to...

International Isotopes Inc. Announces Execution Of A Contract Manufacturing Agreement With Progenics Pharmaceuticals, Inc.

IDAHO FALLS, Idaho, April 9, 2019 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) (the "Company") has announced it has executed a manufacturing and supply agreement with Progenics Pharmaceuticals Inc. ("Progenics"). Under this agreement, the Company will provide contract...

International Isotopes Inc. Announces a Long-Term Supply Agreement For I-131 With The University Of Missouri Research Reactor

IDAHO FALLS, Idaho, Nov. 13, 2018 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) (the "Company") in conjunction with the University Of Missouri Research Reactor (MURR), is pleased to announce it has recently received its first commercial shipment of I-131 from MURR. This...

International Isotopes Inc. Is Awarded Multiple New Radiological Field Service Contracts

IDAHO FALLS, Idaho, Oct. 2, 2018 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) (the "Company") has announced it has recently been awarded more than a dozen contracts for various types of radiological field services involving sealed radioactive source recovery operations. The...

International Isotopes Inc. Announces Financial Results For The Second Quarter 2018

IDAHO FALLS, Idaho, Aug. 15, 2018 /PRNewswire/ -- International Isotopes Inc. (OTCQB: INIS) (the "Company") announces its financial results for the three and six months ended June 30, 2018. Revenue for the three months ended June 30, 2018 was $2,392,306 as compared to $1,785,824 for the...

International Isotopes Frequently Asked Questions

  • When was International Isotopes founded?

    International Isotopes was founded in 1995.

  • How many employees does International Isotopes have?

    International Isotopes has 30 employees.

  • Who are International Isotopes competitors?

    Competitors of International Isotopes include Capital Rx, Antipodean Pharmaceuticals and Boiron.

  • Where is International Isotopes headquarters?

    International Isotopes headquarters is located at 4137 Commerce Cir, Idaho Falls.

  • Where are International Isotopes offices?

    International Isotopes has an office in Idaho Falls.

  • How many offices does International Isotopes have?

    International Isotopes has 1 office.